← Leaderboards

Karen L. Kotloff

University Of Maryland Baltimore

Google Scholar ↗PubMed ↗ORCID ↗

$76,457,208

Attributed

$81,631,730

Total exposure

8

Grants

6

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $25.9M · FY2005–25

$50M$37.5M$25M$12.5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$81,631,730 · 8

By mechanism

UM1$51,811,326 · 1

N01$22,012,938 · 2

U01$6,899,363 · 1

M01$877,272 · 3

U54$30,831 · 1

Top collaborators

Most similar at University Of Maryland Baltimore

Same institution · by research overlap

James B Kaper$25,841,976
James P. Nataro$22,975,369
Wilbur H. Chen$12,119,388
Marcela F Pasetti$26,884,335
Myron Max Levine$22,681,817

Others in their field

Top investigators on “Vaccines”

Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
Bambra Strokes · Ppd Development Lp$526,656,217
Barton F Haynes · Duke University$515,215,260
Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Dennis R. Burton · Scripps Research Institute$316,106,418

Research focus

VaccinesResourcesEvaluationDesignContractsInvestigationConduct Clinical TrialsClinical TrialsNamed GroupInfectious Disease TreatmentRouteVaccine CandidatePreventInfectionVaccine DevelopmentCommunicable DiseasesProtocols DocumentationPublic HealthUniversitiesMarylandMedical SchoolsInnovationProgramsRegulation

Grant awards (77)

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site$1,515,427

UM1 · FY2025 · AI · contact PI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site$1,045,138

UM1 · FY2025 · AI · contact PI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site$1,752,798

UM1 · FY2024 · AI · contact PI

Bacteriophage-based approach for managing Shigella infections$1,162,758

U01 · FY2024 · AI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site$3,268,655

UM1 · FY2023 · AI · contact PI

Bacteriophage-based approach for managing Shigella infections$1,172,622

U01 · FY2023 · AI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site$3,959,354

UM1 · FY2022 · AI · contact PI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site$2,098,592

UM1 · FY2022 · AI · contact PI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site$1,818,913

UM1 · FY2022 · AI · contact PI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site$1,813,428

UM1 · FY2022 · AI · contact PI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site: COVPN 3004 Boost$1,382,804

UM1 · FY2022 · AI · contact PI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site$1,188,978

UM1 · FY2022 · AI · contact PI

Bacteriophage-based approach for managing Shigella infections$1,171,611

U01 · FY2022 · AI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site$563,973

UM1 · FY2022 · AI · contact PI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site$298,077

UM1 · FY2022 · AI · contact PI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site$169,734

UM1 · FY2022 · AI · contact PI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site:21-0011$11,669,935

UM1 · FY2021 · AI · contact PI

VTEU Supplement$5,179,983

UM1 · FY2021 · AI · contact PI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site$2,095,587

UM1 · FY2021 · AI · contact PI

Vaccine Treatment Evaluation Units(VTEU) mRNA-1273-P204 Moderna Pediatric$1,585,845

UM1 · FY2021 · AI · contact PI

Bacteriophage-based approach for managing Shigella infections$1,439,728

U01 · FY2021 · AI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site$1,254,364

UM1 · FY2021 · AI · contact PI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site: DMID 21-0012 Mix and Match$1,121,472

UM1 · FY2021 · AI · contact PI

UMB Vaccine Treatment Evaluation Unit - DMID21-0004$667,476

UM1 · FY2021 · AI · contact PI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site: CoVPN 3004$509,201

UM1 · FY2021 · AI · contact PI

Vaccine and Treatment Evaluation Unit: Phase I/II Malaria Vaccine Trial$424,855

N01 · FY2021 · AI · contact PI

Vaccine Treatment Evaluation Units: Infectious Diseases Clinical ResearchConsortium$5,485,854

UM1 · FY2020 · AI · contact PI

Bacteriophage-based approach for managing Shigella infections$1,952,644

U01 · FY2020 · AI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) clinical site protocols$751,162

UM1 · FY2020 · AI · contact PI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) clinical site protocols$614,576

UM1 · FY2020 · AI · contact PI

Vaccine and Treatment Evaluation Unit: Phase 1 Malaria Vaccine Trial$610,035

N01 · FY2020 · AI · contact PI

Vaccine and Treatment Evaluation Units: Phase I Malaria Vaccine Trial$206,171

N01 · FY2020 · AI · contact PI

Phase 1 Malaria Vaccine Trial - VTEU$112,851

N01 · FY2019 · AI · contact PI

VTEU: Phase I Malaria Vaccine Clinical Trial$845,285

N01 · FY2016 · AI · contact PI

Phase II trial of Meningococcal Vaccines in Pregnant Women - VTEU$139,652

N01 · FY2016 · AI · contact PI

Vaccine and Treatment Evaluation Unit$131,497

N01 · FY2016 · AI · contact PI

VTEU: Phase 2 Trial to Evaluate Staphylococcus Aureus Therapeutics$98,832

N01 · FY2016 · AI · contact PI

Phase 1 Malaria Vaccine Trial - VTEU$1,555,265

N01 · FY2015 · AI · contact PI

Vaccine and Treatment Evaluation Unit$363,918

N01 · FY2015 · AI · contact PI

VACCINE AND TREATMENT EVALUATION UNITS$343,826

N01 · FY2015 · AI · contact PI

Phase II trial of Meningococcal Vaccines in Pregnant Women - VTEU$212,465

N01 · FY2015 · AI · contact PI

Vaccine and Treatment Evaluation Units$171,226

N01 · FY2015 · AI · contact PI

Phase I Malaria Vaccine Trial - VTEU$115,962

N01 · FY2015 · AI · contact PI

Phase I Malaria Vaccine Clinical Trial - VTEU$90,057

N01 · FY2015 · AI · contact PI

Vaccine and Treatment Evaluation Units$84,504

N01 · FY2015 · AI · contact PI

Phase II Trial of H7N9 Influenza Vaccines - VTEU$1,098,151

N01 · FY2014 · AI · contact PI

Safety and Immunogenicity of H3N2v Influenza Vaccine in Pediatric Populations - VTEU$429,097

N01 · FY2014 · AI · contact PI

Vaccine and Treatment Evaluation Units$344,492

N01 · FY2014 · AI · contact PI

VACCINE AND TREATMENT EVALUATION UNITS$301,498

N01 · FY2014 · AI · contact PI

Vaccine and Treatment Evaluation Units$300,000

N01 · FY2014 · AI · contact PI

Phase 1 Malaria Vaccine Trial - VTEU$67,121

N01 · FY2014 · AI · contact PI

Vaccine and Treatment Evaluation Units$4,402

N01 · FY2014 · AI · contact PI

Vaccine and Treatment Evaluation Units$300,025

N01 · FY2013 · AI · contact PI

VACCINE AND TREATMENT EVALUATION UNITS$165,729

N01 · FY2013 · AI · contact PI

Vaccine and Treatment Evaluation Units$135,867

N01 · FY2013 · AI · contact PI

VACCINE AND TREATMENT EVALUATION UNITS$50,000

N01 · FY2013 · AI · contact PI

VACCINE AND TREATMENT EVALUATION UNITS$794,044

N01 · FY2012 · AI · contact PI

Vaccine and Treatment Evaluation Units$548,024

N01 · FY2012 · AI · contact PI

VACCINE AND TREATMENT EVALUATION UNITS$500,000

N01 · FY2012 · AI · contact PI

VACCINE AND TREATMENT EVALUATION UNITS$500,000

N01 · FY2012 · AI · contact PI

Vaccine and Treatment Evaluation Units$300,000

N01 · FY2012 · AI · contact PI

VACCINE AND TREATMENT EVALUATION UNITS$50,000

N01 · FY2012 · AI · contact PI

VACCINE AND TREATMENT EVALUATION UNITS$1,100,000

N01 · FY2011 · AI · contact PI

Vaccine and Treatment Evaluation Units$1,000,000

N01 · FY2011 · AI · contact PI

VACCINE AND TREATMENT EVALUATION UNITS$1,000,000

N01 · FY2011 · AI · contact PI

VACCINE AND TREATMENT EVALUATION UNITS$1,000,000

N01 · FY2011 · AI · contact PI

VACCINE AND TREATMENT EVALUATION UNITS$1,000,000

N01 · FY2011 · AI · contact PI

VACCINE AND TREATMENT EVALUATION UNITS$1,000,000

N01 · FY2011 · AI · contact PI

Vaccine and Treatment Evaluation Units$300,000

N01 · FY2011 · AI · contact PI

Vaccine and Treatment Evaluation Units$2,831,917

N01 · FY2010 · AI · contact PI

Vaccine and Treatment Evaluation Units$386,170

N01 · FY2010 · AI · contact PI

Vaccine and Treatment Evaluation Units$1,000,000

N01 · FY2009 · AI · contact PI

CLINICAL TRIAL: PHASE 1 STUDY OF THE SAFETY & IMMUNOGENICITY OF SHIGELLA/ETEC VA$196,373

M01 · FY2008 · RR · contact PI

UMB Clinical Core$30,831

U54 · FY2008 · AI · contact PI

SHIGELLA CVD 25000G: PHASE 1, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, D$196,045

M01 · FY2007 · RR · contact PI

PHASE I TRIAL OF LIVE ORAL ATTENUATED SHIGELLA FLEXNERI 2A VACCINE CVD 1208S$307,908

M01 · FY2005 · RR

Phase 1 trial of live/oral/attenuated Shigella flexneri$176,946

M01 · FY2004 · RR